Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
11/15/2023 | $11.00 → $1.50 | Buy → Hold | Jefferies |
11/14/2023 | $10.00 → $2.50 | Buy → Hold | Canaccord Genuity |
11/14/2023 | Neutral → Underweight | JP Morgan | |
11/14/2023 | $12.00 → $2.00 | Overweight → Underweight | Piper Sandler |
11/14/2023 | $9.00 → $2.50 | Outperform → Market Perform | TD Cowen |
11/14/2023 | Buy → Hold | The Benchmark Company | |
11/14/2023 | Mkt Perform → Underperform | Raymond James | |
11/14/2023 | Outperform → Mkt Perform | William Blair |
Delivers third quarter net sales of $78.8 million; Delivers improved profitability as strategic initiatives start to take hold Successfully launches Hydralock HA Booster The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2024 ("Q3 2024"). "We delivered revenue above the midpoint of our guidance, with growth in consumables sales driven by sustained demand for Hydrafacial treatments and the successful launch of the Hydralock HA Booster," said BeautyHealth Chief Executive Officer Marla Beck. "Our ability to expand gross margins and achieve adjusted EBITDA profitability
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report third quarter 2024 financial results after market close on Tuesday, November 12, 2024. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Information The Beauty Health Company announces material information to the public through a varie
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, announced today that a video poster abstract presentation on the efficacy and safety of Hydrafacial treatments combined with non-ablative fractional laser and intense pulsed light (IPL) full-face treatments will be featured at the American Society for Dermatologic Surgery (ASDS) meeting in Orlando, Florida from October 17-20, 2024. "This presentation on the clinical efficacy and safety of Hydrafacial treatments combined with non-ablative fractional laser or IPL full-face treatments represents a significant milestone for Hydrafacial," said Marla Beck, Chief Executive Officer of BeautyHealth. "Although Hydrafacial
Jefferies downgraded The Beauty Health Company from Buy to Hold and set a new price target of $1.50 from $11.00 previously
JP Morgan downgraded The Beauty Health Company from Neutral to Underweight
Canaccord Genuity downgraded The Beauty Health Company from Buy to Hold and set a new price target of $2.50 from $10.00 previously
Delivers third quarter net sales of $78.8 million; Delivers improved profitability as strategic initiatives start to take hold Successfully launches Hydralock HA Booster The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2024 ("Q3 2024"). "We delivered revenue above the midpoint of our guidance, with growth in consumables sales driven by sustained demand for Hydrafacial treatments and the successful launch of the Hydralock HA Booster," said BeautyHealth Chief Executive Officer Marla Beck. "Our ability to expand gross margins and achieve adjusted EBITDA profitability
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report third quarter 2024 financial results after market close on Tuesday, November 12, 2024. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Information The Beauty Health Company announces material information to the public through a varie
Delivers second quarter net sales of $90.6 million; Year-over-year operating expense improvement of nearly $18 million or 22%; Revises full year financial guidance The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the second quarter ended June 30, 2024 ("Q2 2024"). For the quarter, net sales of $90.6 million decreased (22.9)% relative to the same period in 2023. Second quarter results reflect lower equipment sales partially offset by steady growth in consumables net sales. "Our second quarter results reflect continued demand for Hydrafacial treatments with growth in consumables sales, offset by a slowe
SC 13G/A - Beauty Health Co (0001818093) (Subject)
SC 13G/A - Beauty Health Co (0001818093) (Subject)
SC 13G/A - Beauty Health Co (0001818093) (Subject)
4 - Beauty Health Co (0001818093) (Issuer)
4 - Beauty Health Co (0001818093) (Issuer)
4 - Beauty Health Co (0001818093) (Issuer)
4 - Beauty Health Co (0001818093) (Issuer)
4 analysts have expressed a variety of opinions on Beauty Health (NASDAQ:SKIN) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 1 2 0 Last 30D 0 0 0 1 0 1M Ago 0 0 0 0 0 2M Ago 1 0 1 0 0 3M Ago 0 0 0 1 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $3.0, with a high estimate of $5.00 and a low estimate of $1.50. A decline of 17.
Piper Sandler analyst Korinne Wolfmeyer maintains Beauty Health (NASDAQ:SKIN) with a Underweight and lowers the price target from $2.5 to $1.5.
Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI) fell sharply during Monday's session after the company priced a $1.7 million public offering of 8.5 million shares of common stock at $0.20 per share. Virios Therapeutics shares dipped 47.6% to $0.1850 on Monday. Here are some other stocks moving in today’s mid-day session. Gainers MultiMetaVerse Holdings Limited (NASDAQ:MMV) shares jumped 224% to $2.01. MultiMetaVerse Holdings signed a non-binding term sheet to acquire 100% of Bowong Technology (Shenzhen) Co., Ltd. and its subsidiaries. GT Biopharma, Inc. (NASDAQ:GTBP) rose 146% to $7.64. GT Biopharma, last week, posted a narrower-than-expected quarterly loss. Tantech Hold
8-K - Beauty Health Co (0001818093) (Filer)
8-K/A - Beauty Health Co (0001818093) (Filer)
8-K - Beauty Health Co (0001818093) (Filer)
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of two accomplished industry executives to its commercial leadership team. Ron Menezes will join Beauty Health as Chief Revenue Officer and Carrie Caulkins will join the Company as Chief Marketing Officer, effective October 15, 2024, with both reporting to the Company's Chief Executive Officer, Marla Beck. Mr. Menezes assumes his new role from Dan ("Doc") Watson, who is leaving Beauty Health and will assist with the transition through year-end. Ms. Caulkins fills an open position. Marla Beck commented on the appointments, "We are thrilled to welcome Ron and Carrie to the executive t
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced that it has appointed Sheri Lewis as Chief Supply Chain and Operations Officer, effective immediately. Ms. Lewis will report to BeautyHealth's President and Chief Executive Officer, Marla Beck. "Sheri is a talented and deeply experienced executive who brings decades of valuable global operations expertise to BeautyHealth as we chart the future of the Company," said Marla Beck, BeautyHealth President and Chief Executive Officer. "The Board of Directors and I are confident that her deep industry experience across global supply chain and operations will play a critical role in advancing our strategic
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced its Board of Directors has unanimously approved Marla Beck as the Company's permanent President and Chief Executive Officer. Ms. Beck has been Interim CEO since November 20, 2023, in addition to serving on the Company's Board of Directors, which she will continue to do going forward. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312423257/en/SKIN) (Photo: Business Wire)">Marla Beck, President and Chief Executive Officer, The Beauty Health Company (NASDAQ:SKIN) (Photo: Business Wire) "Over the past few months, the Board has undertaken